List of works - Marek Niedoszytko

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

scientific article published on 08 June 2020

Analysis of deaths caused by obstructive pulmonary diseases in Pomerania province in 2001-2004

scientific article

Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.

scientific article published on 2 July 2008

Analysis of the differences in whole-genome expression related to asthma and obesity

scientific article published on 07 August 2015

Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma

scientific article published on 01 February 2007

Association between the -1154 G/A promoter polymorphism of the vascular endothelial growth factor gene and atopic dermatitis

scientific article published on 08 June 2009

Association of mastocytosis with interleukin 31 gene polymorphism

scientific article published on 11 March 2015

Asthma control uncontrolled.

scientific article

Asthma prevalence and risk factors analysis in Tricity university students' group.

scientific article published on January 2015

COMMD8 changes expression during initial phase of wasp venom immunotherapy

scientific article published on 19 June 2020

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

scientific article published in 2021

Cardiopulmonary exercise test and bioimpedance as prediction tools to predict the outcomes of obesity treatment

scientific article published on 07 March 2019

Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients

scientific article published on 16 February 2011

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis

scientific article published on 02 January 2021

Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis

scientific article published in July 2021

Clinical Value of Conjunctival Allergen Challenge in Diagnosing Allergic Conjunctivitis Related to Latex ⬇️

scientific article published on August 24, 2010

Clinical aspects of paediatric mastocytosis: a review of 101 cases

scientific article

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

scientific article published on 28 February 2020

Clinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latex

scientific article published on 03 May 2007

Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis

scientific article

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

scientific article published on 15 October 2015

Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis

scientific article published on 01 January 2021

Diagnosis of Mastocytosis in Children and Adults in Daily Clinical Practice

scientific article

Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine

scientific article published on 27 November 2020

Differences in gene expression related to the results of obesity treatment, peak oxygen uptake and fatty acid metabolism measured in a cardiopulmonary exercise test.

scientific article published on 26 March 2018

Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature

scientific article published on 18 November 2011

Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?

scientific article published on 15 November 2014

Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients

scientific article published on 15 March 2014

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives

scientific article

Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations.

scientific article published on January 2014

Fungal allergy--part II

scientific article published in April 2002

Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy.

scientific article published on 27 October 2013

Gene expression analysis in predicting the effectiveness of insect venom immunotherapy

scientific article published on 23 March 2010

Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.

scientific article published on 08 December 2010

Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis.

scientific article

Genetic and Epigenetic Aspects of Atopic Dermatitis

scientific article published on 04 September 2020

Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

scientific article published in 2022

Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

scientific article published on 10 August 2020

How to diagnose Mast Cell Activation Syndrome? Practical considerations

scientific article published on 25 February 2020

Impairment of lung diffusion capacity-a new consequence in the long-term childhood leukaemia survivors

scientific article published on 02 July 2019

Improvement of daily allergy control by sublingual immunotherapy: A <scp>MASK</scp>‐air® study

scientific article published in 2023

Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population

scientific article published on 17 September 2009

Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis

scientific article

Interleukin-31 Polymorphisms and Serum IL-31 Level in Patients with Mastocytosis: Correlation with Clinical Presen-tation and Pruritus.

scientific article

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

scientific article published on 31 October 2019

Late-phase allergic reaction in nasal provocation with fungal allergens

scientific article published on 01 January 2008

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

scientific article published on 6 January 2017

Mast cells in mastocytosis and allergy - Important player in metabolic and immunological homeostasis

scientific article published on 11 January 2019

Mastocytosis--mastcell proliferative disease risk of anaphylactic reaction

scientific article published in December 2006

MicroRNAs: future biomarkers and targets of therapy in asthma?

scientific article published on 01 May 2020

New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood

scientific article published on 04 May 2020

Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis

scientific article published on 27 May 2011

Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report

scientific article published in 2023

Persistent impact of cigarette smoking on asthma.

scientific article published in August 2008

Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice

scientific article published in 2022

Position statement of expert panel of the Polish Allergology Society on the management of patients with bronchial asthma and allergic diseases during SARS-Cov-2 pandemics

scientific article published on 20 April 2020

Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).

scientific article published on 21 January 2016

Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

scientific article published on 18 November 2019

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

scientific article published on 05 February 2019

Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis

scientific article published in 2022

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

scientific article published on 19 May 2014

Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

scientific article published in 2022

Results from a Genome-Wide Association Study (GWAS) in Mastocytosis Reveal New Gene Polymorphisms Associated with WHO Subgroups

scientific article published on 31 July 2020

Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

scientific article published in 2023

Risk and Management of Patients with Mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) Pandemic: Expert Opinions

scientific article published on 16 June 2020

Risk factors for anaphylaxis in patients with mastocytosis

scientific article published on 12 January 2015

Scoring the risk of having systemic mastocytosis in adult patients with mastocytosis in the skin

scientific article published on 17 December 2020

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

scientific article published in 2021

Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement

scientific article

Side effects of specific immunotherapy in patients with hymenoptera venom allergy

scientific article published in January 2005

Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis

scientific article published on 30 December 2019

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives

scientific article published on 08 November 2018

The Possible Role of Gene Variant Coding Nonfunctional Toll-Like Receptor 2 in the Pathogenesis of Mastocytosis

scientific article published on 15 June 2018

The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis.

scientific article published on 16 April 2016

The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens.

scientific article published on 22 April 2010

The influence of obesity on inflammation and clinical symptoms in asthma.

scientific article published on January 2013

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions

scientific article published on 31 July 2017

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.

scientific article

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.

scientific article

Transient improvement of skin symptoms in an adult patient with pediatric-onset cutaneous mastocytosis treated with interferon-α

scientific article published on 06 April 2018

Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

scientific article published in 2021

[Cancer related fatigue. I. Prevalence and attempt to define the problem]

scientific article published on 01 January 2004

[Fungal allergy. Part I]

scientific article published on 01 March 2002

[Quality of life of patients with asthma which has been well and poorly controlled]

scientific article published on 01 January 2007

[Systemic mastocytosis]

scientific article published on 01 January 2005

miRNA profiles change during grass pollen immunotherapy irrespective of clinical outcome

scientific article published on 14 February 2022

List of works by Marek Niedoszytko

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

Analysis of deaths caused by obstructive pulmonary diseases in Pomerania province in 2001-2004

Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.

Analysis of the differences in whole-genome expression related to asthma and obesity

Association between sensitization to Aureobasidium pullulans (Pullularia sp) and severity of asthma

Association between the -1154 G/A promoter polymorphism of the vascular endothelial growth factor gene and atopic dermatitis

Association of mastocytosis with interleukin 31 gene polymorphism

Asthma control uncontrolled.

Asthma prevalence and risk factors analysis in Tricity university students' group.

COMMD8 changes expression during initial phase of wasp venom immunotherapy

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)

Cardiopulmonary exercise test and bioimpedance as prediction tools to predict the outcomes of obesity treatment

Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients

Clinical Impact of Inherited and Acquired Genetic Variants in Mastocytosis

Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis

Clinical Value of Conjunctival Allergen Challenge in Diagnosing Allergic Conjunctivitis Related to Latex ⬇️

Clinical aspects of paediatric mastocytosis: a review of 101 cases

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Clinical value of conjunctival allergen challenge in diagnosing allergic conjunctivitis related to latex

Comparative analysis of IL6 and IL6 receptor gene polymorphisms in mastocytosis

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis

Diagnosis of Mastocytosis in Children and Adults in Daily Clinical Practice

Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine

Differences in gene expression related to the results of obesity treatment, peak oxygen uptake and fatty acid metabolism measured in a cardiopulmonary exercise test.

Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature

Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?

Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients

European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives

Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations.

Fungal allergy--part II

Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy.

Gene expression analysis in predicting the effectiveness of insect venom immunotherapy

Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis.

Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis.

Genetic and Epigenetic Aspects of Atopic Dermatitis

Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium

Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

How to diagnose Mast Cell Activation Syndrome? Practical considerations

Impairment of lung diffusion capacity-a new consequence in the long-term childhood leukaemia survivors

Improvement of daily allergy control by sublingual immunotherapy: A <scp>MASK</scp>‐air® study

Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish population

Interleukin-13 promoter gene polymorphism -1112C/T is associated with the systemic form of mastocytosis

Interleukin-31 Polymorphisms and Serum IL-31 Level in Patients with Mastocytosis: Correlation with Clinical Presen-tation and Pruritus.

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

Late-phase allergic reaction in nasal provocation with fungal allergens

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Mast cells in mastocytosis and allergy - Important player in metabolic and immunological homeostasis

Mastocytosis--mastcell proliferative disease risk of anaphylactic reaction

MicroRNAs: future biomarkers and targets of therapy in asthma?

New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood

Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis

Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report

Persistent impact of cigarette smoking on asthma.

Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice

Position statement of expert panel of the Polish Allergology Society on the management of patients with bronchial asthma and allergic diseases during SARS-Cov-2 pandemics

Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).

Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

Proposed European Competence Network on Mastocytosis—American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium

Results from a Genome-Wide Association Study (GWAS) in Mastocytosis Reveal New Gene Polymorphisms Associated with WHO Subgroups

Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

Risk and Management of Patients with Mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) Pandemic: Expert Opinions

Risk factors for anaphylaxis in patients with mastocytosis

Scoring the risk of having systemic mastocytosis in adult patients with mastocytosis in the skin

Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review

Self-medication of anaphylactic reactions due to Hymenoptera stings-an EAACI Task Force Consensus Statement

Side effects of specific immunotherapy in patients with hymenoptera venom allergy

Smoking history is negatively associated with allergen specific immunotherapy efficacy: a retrospective analysis

The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives

The Possible Role of Gene Variant Coding Nonfunctional Toll-Like Receptor 2 in the Pathogenesis of Mastocytosis

The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis.

The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens.

The influence of obesity on inflammation and clinical symptoms in asthma.

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part I: Treg properties and functions

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.